HER2 Support Group Forums
>
Articles of Interest
RSR13 (efaproxiral) on Fast-Track for Brain Metastases
User Name
Remember Me?
Password
Register
Gallery
FAQ
Members List
Calendar
Today's Posts
Search
Search Forums
Show Threads
Show Posts
Advanced Search
Search Gallery
Advanced Search
Go to Page...
Thread Tools
Display Modes
06-01-2003, 08:48 PM
#
1
Lolly
Guest
Posts: n/a
In Phase III trials patients with metastatic breast cancer who received WBR plus RSR13 achieved longer survival. RSR13 works by sensitizing oxygen-deprived tumor tissues to enhance the effectiveness of standard radiation therapy and chemotherapy.
Lolly
«
Previous Thread
|
Next Thread
»
Thread Tools
Show Printable Version
Email this Page
Display Modes
Switch to Linear Mode
Hybrid Mode
Switch to Threaded Mode
Posting Rules
You
may not
post new threads
You
may not
post replies
You
may not
post attachments
You
may not
edit your posts
BB code
is
On
Smilies
are
On
[IMG]
code is
On
HTML code is
On
Forum Rules
Forum Jump
User Control Panel
Private Messages
Subscriptions
Who's Online
Search Forums
Forums Home
her2group
Herceptin / Tykerb
Caregivers Corner
Diet and Nutrition
Inflammatory Breast Cancer
Keeping Your Mind Off of BC
Profiles In Courage
My Healthcare Team
Clinical Trials
Articles of Interest
Events and Social Calendar
Breast Cancer Meeting Highlights
General Cancer News
Breast Cancer News
Breast Cancer Newsfeed
All times are GMT -7. The time now is
10:09 PM
.